Advertisement
Advertisement
Advertisement

Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
DOI: http://dx.doi.org/10.1160/TH11-11-0788
Issue: 2012: 107/6 (June) pp. 1009–1194
Pages: 1189-1191

Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency

C. Hermans (1), S. Eeckhoudt (2), C. Lambert (1)

(1) Hemostasis and Thrombosis Unit, Division of Adult Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; (2) Hemostasis and Thrombosis Laboratory, Division of Biological Chemistry, Cliniques Universitaires Saint-Luc, Brussels, Belgium

DOI

http://dx.doi.org/10.1160/TH11-11-0788

Thrombosis News

Mobile technology identifies people with unknown atrial fibrillation at high risk of stroke – article published in Thrombosis and Haemostasis

The article “Feasibility and cost effectiveness of stroke prevention through community screening...

TH 111.4

The April 2014 TH 111.4 issue of Thrombosis and Haemostasis is a Theme Issue by Guest Editor B....

TH 111.3

Women with atrial fibrillation have a much higher risk for thromboembolic stroke than men suffering...